Rockwell Automation Announces Leadership Changes: Blake Moret Named CEO, Keith Nosbusch to Remain Chairman
Rockwell Automation (NYSE:ROK) announced today that its board of directors has elected Blake D. Moret, a 30-year veteran of the Company, as president and chief executive officer, effective July 1, 2016. At that time Keith D. Nosbusch, 65, who has been president and chief executive officer since 2004, will transition from those roles while continuing as chairman of the board. Moret, 53, is currently senior vice president of the Company’s Control Products & Solutions segment.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160419005578/en/
Rockwell Automation announces leadership changes: Blake Moret named CEO, Keith Nosbusch to remain chairman. (Photo: Business Wire)
Donald R. Parfet, Lead Director, said: “Blake has proven himself to be an exceptional leader, with demonstrated readiness to lead the company. We welcome him to his new role at the conclusion of a deliberate and planned succession process. We are delighted he will build on the Company’s many accomplishments under Keith’s direction and propel our vision of The Connected Enterprise to the next level.”
“The past 12 years have been transformational for Rockwell Automation,” Parfet continued. “We’ve become a global technology leader and the world’s largest company dedicated to industrial automation and information. Equally important, we are well positioned to accelerate our evolution with industry-leading innovation that improves our customers’ global competitiveness.”
“We thank Keith for his outstanding leadership during this period, including his work as a vocal champion of smart, productive, and secure manufacturing. We are pleased that he has agreed to stay on as chairman so that the Company can continue to benefit from his experience and support Blake’s transition to CEO.”
Nosbusch said: “It has been an honor and privilege to lead Rockwell Automation over the past 12 years. While as a team we enjoyed tremendous success, I have no doubt that we are well positioned for an even greater future. Blake is the ideal executive to move Rockwell Automation forward in its next chapter. He brings a strong customer focus, as well as a deep understanding of the Company’s values, culture, people, and technology, and how each of these power the Company’s success.”
Moret said: “I am honored to have the opportunity to lead Rockwell Automation and its talented employees into an exciting future. We have a deep management team, unmatched technology solutions, domain expertise across a broad range of industries, and enduring customer relationships around the world. We are committed to continue to deliver customer and shareowner value in the years ahead.”
Moret has 30 years of experience in sales and business management roles in product, services, and solutions businesses across Rockwell Automation. He began his career in 1985 as a sales trainee, and subsequently served in senior positions across the organization, including international assignments in Europe and Canada. In 2011, he was named senior vice president of Control Products & Solutions, one of the Company’s two business segments, with FY15 sales of $3.6 billion.
Moret is a graduate of Georgia Institute of Technology, where he earned a bachelor’s degree in mechanical engineering. He has served as Chair of the Board of the Manufacturing Institute of the National Association of Manufacturers. Additionally, he is a member of the Board of Directors for the Milwaukee-based Urban Ecology Center, the Board of Directors of the United Way of Greater Milwaukee, and the Advisory Board of the Woodruff School of Mechanical Engineering at Georgia Tech.
Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and information, makes its customers more productive and the world more sustainable. Headquartered in Milwaukee, Wis., Rockwell Automation employs over 22,000 people serving customers in more than 80 countries
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia12.12.2017 00:30 | Pressemelding
Kite, a Gilead Company (Nasdaq: GILD), announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen receptor T (CAR T) cell therapy, which is investigational for the treatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL). With a minimum of eight weeks of follow-up, 71 percent of ALL patients (n=17/24) who received a single infusion of KTE-C19 achieved complete tumor remission (complete remission (CR) or CR with incomplete hematological recovery). The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the American Society of Hematology (ASH) in Atlanta. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005311/en/ ALL is an aggressive type of blood cancer which can also involve the lymph nodes, spleen, liver, central
NTT Communications Strengthens its DDoS Protection Services with New Detection Solution11.12.2017 23:00 | Pressemelding
NTT Communications Corporation (NTT Com), the global data and IP services arm of Fortune Global 500 telecom leader NTT (TYO: 9432), announced that it is expanding its Distributed Denial of Service Protection Services (DPS) with the addition of DPS Detect. This new solution can help customers detect potential attacks directed to their networks and initiate mitigations faster. DDoS attacks can strike at any time, potentially crippling network infrastructure and severely degrading the performance and reachability of a website or other IP-accessible assets. The expanded DPS suite of services will enable Global IP Network customers around the world to easily customize the level of service and assistance that best fits their needs. “Network security is one of the top priorities for our company,” said Michael Wheeler, executive vice president of the NTT Communications
Interactive Brokers Launches Bitcoin Futures Trading at the Start of Trading December 10th, 201711.12.2017 16:28 | Pressemelding
Interactive Brokers Group, Inc. (NASDAQ GS:IBKR), a global electronic brokerage firm, began offering clients the ability to trade bitcoin futures at the start of trading on the Cboe Futures Exchange (CFE) on Sunday night, December 10th, 2017. In addition to offering bitcoin futures from the CFE, under the ticker symbol GXBT, the company plans to offer bitcoin futures from the Chicago Mercantile Exchange (CME) at the scheduled start of trading December 18th using the symbol BRR. IBKR was there at the start of trading and its systems operated normally. “Interactive Brokers was on the buy side of the low print of 14,710,” said Thomas Peterffy, founder, Chairman and CEO of Interactive Brokers. “A Registered Investment Advisor on the Interactive Brokers platform purchased two March contracts in the first minute of trading.” As of 9:15am ET on Monday, the company said that
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 201711.12.2017 13:00 | Pressemelding
2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities to the Boehringer Ingelheim oncology portfolio and novel therapies to patients. “Immuno-oncology is radically shifting the research and treatment landscape in oncology. We believe that the greatest success in difficult-to-treat cancers will be achieved with immuno-oncology and its combination with cancer cell directed therapy, which is why we are committing significant resources in both areas,” said Jonathon Sedgwick, Ph.D., Vice
Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses11.12.2017 12:47 | Pressemelding
The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 billion. The transaction is expected to close during the first half of 2018. The Businesses, headquartered in St. Louis, Missouri, have global operations and are market leaders in each of their segments. The ICL Fire Safety business is a formulator and manufacturer of fire management chemicals. Its Phos-Chek fire retardants, Class A and B foams, and water enhancing gels are the world’s leading chemical solutions for managing wildland, military, industrial and municipal fires, and are used in partnership with fire management agencies across the globe. The ICL Oil Additives business provides high quality phosphorus pentasulfide used in the preparation of ZDDP-based lubricant additives, i
Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care11.12.2017 10:18 | Pressemelding
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:X TM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005434/en/ Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom